Why the study?
Is rivaroxaban a safe and effective alternative to traditional anticoagulants for the prevention and treatment of venous thromboembolism and stroke prevention in atrial fibrillation?
Population
Patients undergoing hip or knee arthroplasty, patients with venous thrombosis, and patients with atrial…
Comparison
Rivaroxaban vs Traditional anticoagulants
Design
Review
Authors
Loading...
May inform anticoagulant selection in VTE and AF; leaves open need for prospective comparative trials.
Is rivaroxaban a safe and effective alternative to traditional anticoagulants for the prevention and treatment of venous thromboembolism and stroke prevention in atrial fibrillation?
Rivaroxaban is a promising oral alternative to traditional anticoagulants for VTE and stroke prevention, offering fixed dosing without the need for routine monitoring.
Gulseth et al. (2008) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: